BSECompany Update29 Sept 2026 · 29 Sept 2026, 11:26 pm
Intimation under regulation 30 of LODR Regulation - Change in Management pursuant to approval of members at 33rd Annual General Meeting of the Company.
Kimia Biosciences Ltd · 530313
✦ AI SummaryMgmt Change
Kimia Biosciences Ltd has announced changes in its board of directors following the approval of its 33rd Annual General Meeting. The company has appointed four new directors, including Mr. Amulya Kumar Nayak, Ms. Reema Goyal, Mr. Avinash Prabhat, and Mr. Sameer Goel, who will retire by rotation.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern5/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
5806304b-9bdb-4310-b376-0cdd30cd424f.pdf
View document text
DATE- 29.09.2026
The Manager – Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street, Mumbai – 400001
Scrip Code: 530313
Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Change in Management pursuant to approval
of Members at the 33rd Annual General Meeting.
Dear Sir/Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 33rd Annual
General Meeting (“AGM”) of the Members of Kimia Biosciences Limited (“Company”) was held
on Monday, 28 September 2026 at 3:10 P.M. through Video Conferencing / Other Audio-Visual
Means.
We further inform that the Members of the Company, inter alia, approved the following
resolutions relating to the composition of the Board of Directors:
1. To appoint a director in place of Mr. Sameer Goel (DIN: 00161786), Director, who
retires by rotation, and being eligible, offers himself for re-appointment pursuant to
the provisions of Section 152 of the Companies Act, 2013.
2. To approve appointment of Mr. Amulya Kumar Nayak (DIN: 11667557) as Director
retire by rotation.
3. To approve appointment of Ms. Reema Goyal (DIN: 11266730) as Independent & Non-
Executive Woman Director.
4. To approve appointment of Mr. Avinash Prabhat (DIN:10997441) as independent &
Non Executive Director.
The brief particulars/details of the Directors appointed/re-appointed, as required under
Regulation 30 read with Schedule III of the SEBI LODR Regulations, are enclosed as Annexure
A to this letter.
We further confirm that none of the above Directors is debarred from holding the office of
KIMA BIOSCIENCES LIMITED
ed 0tie/wor
Vil.le h0l Dr Lk
6gel.%.2..
fl. 4964/4.44496.42044
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120
Director by virtue of any order of SEBI or any other such authority.
The above information is being submitted for your information and records.
Thanking you,
For Kimia Biosciences Limited
Abhishek Kumar Pandey
Company Secretary & Compliance Officer
Membership No.: F12457
Date: 29 September 2026
Place: Gurugram, Haryana
KIMA BIOSCIENCES LIMITED
ed 0tie/wor
Vil.le h0l Dr Lk
6gel.%.2..
fl. 4964/4.44496.42044
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120
ANNEXURE- A
Details of Directors Appointed / Re-appointed
Particulars Mr. Amulya Ms. Reema Mr. Avinash Mr. Sameer
Kumar Nayak Goyal Prabhat Goel
Reason for Appointment/ Appointment as Appointment as Re-
change Regularisation Non-Executive Non-Executive appointment as
as Director Independent Independent Director liable
Woman Director Director to retire by
rotation
Date of 28 September 4 April 2026, 4 April 2026, 28 September
appointment / 2026 pursuant to pursuant to 2026
re-appointment approval of approval of
Members at Members at
AGM AGM
Term of Liable to retire Five consecutive Five Liable to retire
appointment by rotation years, from 4 consecutive by rotation
April 2026 to 3 years, from 4
April 2031 April 2026 to 3
April 2031
DIN 11667557 11266730 10997441 00161786
Category Non-Executive Non-Executive Non-Executive Managing
Director Independent Independent Director /
Woman Director Director Director
Brief Profile Given in Given in Given in Given in
Annexure-I Annexure-II Annexure-III Annexure-IV
Disclosure of None None None None
relationships
between
Directors inter-
KIMA BIOSCIENCES LIMITED
ed 0tie/wor
Vil.le h0l Dr Lk
6gel.%.2..
fl. 4964/4.44496.42044
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120
Shareholding in None None None 74.94%
the Company
Debarment by He is not she is not He is not He is not
SEBI / other debarred debarred debarred debarred
authority
ANNEXURE-I
Brief Resume / Expertise Mr. Amulya Kumar Nayak is a seasoned
finance and accounts professional with more
than 32 years of experience in finance,
accounts, taxation, audit, MIS, budgeting,
banking and commercial functions. He has
worked with reputed organisations including
Punj Lloyd Ltd., GTL Ltd., Pepsi Foods Ltd.,
Sterling Holiday Resorts and others. He
possesses strong expertise in ERP systems,
financial controls, statutory
compliance and corporate finance.
ANNEXURE-II
Brief Resume / Expertise Ms. Reema Goyal, aged 31 years, is a
Company Secretary in Practice and B.Com
graduate. She has more than five years of
experience in Corporate Law, Companies
Act, SEBI Laws and other law-related
matters. She has knowledge of advisory
services in corporate law, secretarial
compliance, governance advisory, corporate
restructuring and regulatory approvals.
KIMA BIOSCIENCES LIMITED
ed 0tie/wor
Vil.le h0l Dr Lk
6gel.%.2..
fl. 4964/4.44496.42044
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120
ANNEXURE-III
Brief Resume / Expertise Mr. Avinash Prabhat, aged 30 years, is a
Company Secretary by profession and B.Com
graduate. He has more than five years of
experience in Corporate Law, Companies
Act, SEBI Laws and other law related
matters. He contributes to governance,
statutory compliance, risk management and
stakeholder oversight.
ANNEXURE-IV
Brief Resume / Expertise Mr. Sameer Goel is a Delhi University
Commerce graduate and has extensive
experience in the Indian pharmaceutical/API
sector, with expertise in business
development, product development,
strategic marketing and operations
management. He is a founder of Kimia
Biosciences Limited and has substantial
experience in the pharmaceutical APIs
business.
Thanking you,
For Kimia Biosciences Limited
Abhishek Kumar Pandey
Company Secretary & Compliance Officer
Membership No.: F12457
Date: 29 September 2026
Place: Gurugram, Haryana
KIMA BIOSCIENCES LIMITED
ed 0tie/wor
Vil.le h0l Dr Lk
6gel.%.2..
fl. 4964/4.44496.42044
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120